FDA Inspection 1053319 — Institute for Reproductive Health

Institute for Reproductive Health — FEI 3004562849

The FDA completed an inspection of Institute for Reproductive Health on May 23, 2018 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 23, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cincinnati, OH (United States)